Back to results

University of Missouri--Columbia

Gene therapy in mouse models of spinal muscular atrophy :

Abstract

dc:description.abstract

Spinal Muscular Atrophy (SMA), an autosomal recessive neuromuscular disorder, is the leading genetic cause of infant mortality. SMA is caused by the functional, homozygous loss of the Survival Motor Neuron-1 (SMN1) gene which encodes for the ubiquitously expressed Survival Motor Neuron (SMN) protein. Here we utilize SMA mouse models to demonstrate that self-complementary Adeno-associated virus encoding SMN1 (scAAV-SMN) is a promising therapeutic for the treatment of SMA. We show that pre-symptomatic, ubiquitous restoration of SMN via scAAV is able to dramatically improve the SMA phenotype extending lifespan from ̃14 to 200+ days. We show that direct delivery of scAAV-SMN into the central nervous system is able to more robustly rescue the phenotype of a mouse model of SMA compared to systemic, intravascular delivery. After determining the most efficacious route of injection, we seek to determine the therapeutic window and investigate the effectiveness of viral delivery after the onset of disease symptoms. We report that early, pre-symptomatic scAAV-SMN delivery produces a better phenotypic rescue than treatment after the onset of symptoms, emphasizing the need for early therapeutic intervention. We assess the need for SMN in a specific cell population, upper cortical motor neurons, reporting that restoration of SMN to solely to these cells is not sufficient to modify the SMA phenotype. Lastly, we use the scAAV vector to delivery mutant forms of SMN and other genes which may be able to modify the SMA phenotype. In this experiment, we identify several modifying genes which are able to improve the phenotype of an intermediate mouse model. Collectively, these studies help to provide insight into the use of scAAV-SMN as a therapeutic and help to address clinically relevant questions about the temporal and spatial requirements of SMN protein during disease progression.

Degree

thesis:*
Name thesis:degree_name
Ph. D.
Level thesis:degree_level
Doctoral
Discipline thesis:degree_discipline
Microbiology (Medicine) (MU)
Grantor dc:publisher
University of Missouri--Columbia
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Glascock, Jacqueline J., 1986-
Advisor dc:contributor.advisor
  • Lorson, Christian L., 1969-

Rights

dc:rights
Statement dc:rights
  • OpenAccess.
Language dc:language.iso
eng, English

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:mospace.umsystem.edu:10355/44658

Chain of custody

source
Harvested from
University of Missouri
Base URL
mospace.umsystem.edu/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Glascock, Jacqueline J., 1986-. Gene therapy in mouse models of spinal muscular atrophy :. Doctoral thesis, University of Missouri--Columbia, 2013. https://hdl.handle.net/10355/44658